Suppr超能文献

血清CA19-9和CA125水平与超声造影参数数据相结合有助于鉴别卵巢浆液性癌与卵巢恶性上皮性癌。

Combination of serum CA19-9 and CA125 levels and contrast-enhanced ultrasound parametric data facilitates to differentiate ovarian serous carcinoma from ovarian malignant epithelial cancer.

作者信息

Zhang Wei, Wang Liying, Xin Zhongqiu

机构信息

Department of Ultrasound, General Hospital of Daqing Oil Field, Daqing, 163001, China.

出版信息

Medicine (Baltimore). 2018 Apr;97(16):e0358. doi: 10.1097/MD.0000000000010358.

Abstract

Ovarian serous carcinoma (OSC) is semimalignant ovarian tumors that localized in the ovary at the initial presentation, and can be surgically resected in an excellent prognosis. In contrast, surgical treatment plus adjuvant chemotherapy for ovarian malignant epithelial cancer (OMEC) is the standard treatment stratagem that is painful with poor prognosis and cost quite expensively. Thus, the accurate preoperative differentiation of OSC from OMEC is important for determining the treatment methods and decreasing the cost for individual patients. This study aims to determine whether contrast enhanced ultrasound (CEUS) together with CA19-9/CA125 can improve the ability to differentiate ovarian serous carcinoma from ovarian malignant epithelial cancer. The positive rate of cancer antigen (CA) 199 and CA125 in ovarian malignant epithelial tumors was 68% and 94%, respectively, which was a higher incidence than in the serous carcinoma. The mean serum CA19-9 and CA125 concentration was significantly higher in the patients with ovarian malignant epithelial tumors (CA19-9, 514.0 ± 104.8 U/mL; CA125, 440.0 ± 154.8 U/mL) than that in the patients with ovarian serous carcinoma (CA19-9, 58.0 ± 14.3 U/mL; CA125, 63.0 ± 25.8 U/mL). The time to peak in ovarian serous carcinoma was significantly longer than in ovarian malignant epithelial tumors. However, the peak intensity, area under the curve, and washout time in ovarian serous carcinoma were significantly lower than in ovarian malignant epithelial tumors. The addition of CA19-9/CA125 increased the sensitivities from 79% CEUS only to 85% for CEUS plus CA19-9/CA125 data, and increased the specificities from 65% CEUS only to 91% for CEUS plus the CA19-9/CA125 information. Thus, the addition of the serum CA19-9/CA125 levels to parametric CEUS data was of significant diagnostic value for differentiating OSC from OMEC.

摘要

卵巢浆液性癌(OSC)是一种半恶性卵巢肿瘤,初发时局限于卵巢,手术切除后预后良好。相比之下,卵巢恶性上皮癌(OMEC)的标准治疗策略是手术治疗加辅助化疗,这种治疗方式痛苦且预后较差,费用也相当昂贵。因此,术前准确区分OSC和OMEC对于确定治疗方法和降低个体患者的费用非常重要。本研究旨在确定超声造影(CEUS)联合CA19-9/CA125能否提高区分卵巢浆液性癌和卵巢恶性上皮癌的能力。卵巢恶性上皮肿瘤中癌抗原(CA)199和CA125的阳性率分别为68%和94%,高于浆液性癌。卵巢恶性上皮肿瘤患者的血清CA19-9和CA125平均浓度(CA19-9,514.0±104.8 U/mL;CA125,440.0±154.8 U/mL)显著高于卵巢浆液性癌患者(CA19-9,58.0±14.3 U/mL;CA125,63.0±25.8 U/mL)。卵巢浆液性癌的达峰时间显著长于卵巢恶性上皮肿瘤。然而,卵巢浆液性癌的峰值强度、曲线下面积和廓清时间显著低于卵巢恶性上皮肿瘤。添加CA19-9/CA125后,敏感度从仅CEUS时的79%提高到CEUS联合CA19-9/CA125数据时的85%,特异度从仅CEUS时的65%提高到CEUS联合CA19-9/CA125信息时的91%。因此,将血清CA19-9/CA125水平添加到CEUS参数数据中对于区分OSC和OMEC具有重要的诊断价值。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验